These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. US relaxes rules for Rx shopping sprees to Canada. Guthrie P CMAJ; 2006 Dec; 175(12):1509. PubMed ID: 17146082 [No Abstract] [Full Text] [Related]
24. TRIPS, pharmaceutical patents, and access to essential medicines: a long way from Seattle to Doha. 't Hoen E Chic J Int Law; 2002; 3(1):27-46. PubMed ID: 15709298 [No Abstract] [Full Text] [Related]
25. Access to essential drugs. Dev World Bioeth; 2001 Nov; 1(2):89-92. PubMed ID: 12870517 [No Abstract] [Full Text] [Related]
26. EU agrees deal on cheaper drugs for developing world. Watson R BMJ; 2003 Jun; 326(7401):1229. PubMed ID: 12791716 [No Abstract] [Full Text] [Related]
27. [How are prices for important drugs stipulated in poor countries?]. Lien L Tidsskr Nor Laegeforen; 2003 Apr; 123(7):958-9. PubMed ID: 12737074 [No Abstract] [Full Text] [Related]
28. Global health and university patents. Kapczynski A; Crone ET; Merson M Science; 2003 Sep; 301(5640):1629. PubMed ID: 14500943 [No Abstract] [Full Text] [Related]
29. More drugs, less protection. Nature; 2002 Sep; 419(6904):233. PubMed ID: 12239521 [No Abstract] [Full Text] [Related]
30. Pharmaceuticals and medical devices: cost savings. End-of-year issue brief. Health Policy Tracking Service, A Service of Thomson Reuters/West Issue Brief Health Policy Track Serv; 2011 Jan; ():1-21. PubMed ID: 21374837 [No Abstract] [Full Text] [Related]
31. Pharmaceuticals and medical devices: business practices. Steiner DJ Issue Brief Health Policy Track Serv; 2013 Dec; ():1-36. PubMed ID: 24482889 [No Abstract] [Full Text] [Related]
32. Should the patent system for new medicines be abolished? DiMasi JA; Grabowski HG Clin Pharmacol Ther; 2007 Nov; 82(5):488-90. PubMed ID: 17952100 [No Abstract] [Full Text] [Related]
33. US drug shortages are set to reach record high in 2011, report says. Tanne JH BMJ; 2011 Dec; 343():d8307. PubMed ID: 22194406 [No Abstract] [Full Text] [Related]
34. Global issues on the agenda at the World Health Assembly: discussion of HIV/AIDS, leprosy, access to drugs. Banta HD JAMA; 2001 Jul; 286(1):29-30. PubMed ID: 11434811 [No Abstract] [Full Text] [Related]
35. The concept of essential medicines: lessons for rich countries. Hogerzeil HV BMJ; 2004 Nov; 329(7475):1169-72. PubMed ID: 15539676 [TBL] [Abstract][Full Text] [Related]
36. Argentina and Cuba agree on trade of "drugs for dollars". Rogers GI Lancet; 2003 Oct; 362(9393):1385. PubMed ID: 14594004 [No Abstract] [Full Text] [Related]
37. UK leads initiative to drive down cost of drugs in poor countries. Short R BMJ; 2007 Apr; 334(7599):870. PubMed ID: 17463440 [No Abstract] [Full Text] [Related]
38. The World Health Organization's prequalification program and its potential effect on data exclusivity laws. Childs DW Food Drug Law J; 2005; 60(1):79-97. PubMed ID: 15940855 [No Abstract] [Full Text] [Related]
39. At what price? Danzon PM Nature; 2007 Sep; 449(7159):176-9. PubMed ID: 17851515 [No Abstract] [Full Text] [Related]